Abstract
Responses to Tamoxifen withdrawal and second line endocrine therapy — Clinical clues to the mechanisms of Tamoxifen failure in patients with advanced breast cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have